Concepedia

Author

Judith Skaptason

Pfizer (United States)

Also Known As

Judith Skaptason, Skaptason, Judith

10

Publications

286

Citations

6

H-Index

20

Concepts

All Affiliations

Pfizer (United States)
JS

About

Judith Skaptason is an author at Pfizer (United States) specializing in medicine, pharmacology, and pharmacotherapy.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

3

3

120

2

Natural Sciences

2

2

108

3

Biochemistry

2

2

108

4

Cell Biology

1

1

12

5

Chemical Biology

1

1

73

Judith Skaptason

×

5

Publications

275

Citations

5

H-Index

YearCitations

Pharmacokinetic-Pharmacodynamic Modeling of Biomarker Response and Tumor Growth Inhibition to an Orally Available cMet Kinase Inhibitor in Human Tumor Xenograft Mouse Models

Shinji Yamazaki, Judith Skaptason, David Romero,

Drug Metabolism and Disposition

2008

94

Dihydroxyphenylisoindoline Amides as Orally Bioavailable Inhibitors of the Heat Shock Protein 90 (Hsp90) Molecular Chaperone

Pei‐Pei Kung, Buwen Huang, Gang Zhang,

Journal of Medicinal Chemistry

2009

73

Prediction of Oral Pharmacokinetics of cMet Kinase Inhibitors in Humans: Physiologically Based Pharmacokinetic Model Versus Traditional One-Compartment Model

Shinji Yamazaki, Judith Skaptason, David Romero,

Drug Metabolism and Disposition

2010

61

Identification of (<i>R</i>)-(2-Chloro-3-(trifluoromethyl)phenyl)(1-(5-fluoropyridin-2-yl)-4-methyl-6,7-dihydro-1<i>H</i>-imidazo[4,5-<i>c</i>]pyridin-5(4<i>H</i>)-yl)methanone (JNJ 54166060), a Small Molecule Antagonist of the P2X7 receptor

Devin M. Swanson, Brad M. Savall, Kevin J. Coe,

Journal of Medicinal Chemistry

2016

35

Pharmacologic properties of AG-012986, a pan-cyclin-dependent kinase inhibitor with antitumor efficacy

Cathy Zhang, Karen Lundgren, Zhengming Yan,

Molecular Cancer Therapeutics

2008

12

Page 1